We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




miRNAs Show Promise for Treatment of Ovarian Cancer

By LabMedica International staff writers
Posted on 21 Aug 2012
Print article
Results of a recent study suggest that microRNAs (miRNAs) have excellent therapeutic potential, which justifies continued research efforts designed to turn them into usable anticancer agents.

Investigators at the Georgia Institute of Technology (Atlanta, GA, USA) worked with two well-defined mRNA species, MiR-7 and MiR-128. They conducted a series of controlled experiments in which these two miRNAs--previously implicated in ovarian cancer onset/progression--were individually transfected into a well-defined ovarian cancer (HEY) cell line, and the consequence on global patterns of gene expression was monitored using microarray technology.

The results published in the August 1, 2012, online edition of the journal BMC Medical Genomics revealed that the changes in gene expression induced by the individual miRNAs were functionally coordinated but distinct between the two miRNAs. MiR-7 transfection into ovarian cancer cells induced changes in cell adhesion and other developmental networks previously associated with epithelial-mesenchymal transitions (EMT) and other processes linked with metastasis. In contrast, miR-128 transfection induced changes in cell cycle control and other processes commonly linked with cellular replication.

“Each inserted miRNA created hundreds of thousands of gene expression changes, but only about 20% of them were caused by direct interactions with mRNAs,” said senior author Dr. John McDonald, professor of biology at the Georgia Institute of Technology. “The majority of the changes were indirect – they occurred downstream and were consequences of the initial reactions. miRNAs have evolved for millions of years in order to coordinately regulate hundreds to thousands of genes together on the cellular level. If we can understand which miRNAs affect which suites of genes and their coordinated functions, it could allow clinicians to attack cancer cells on a systems level, rather than going after genes individually”.

Related Links:
Georgia Institute of Technology



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Chlamydia Test Kit
CHLAMYTOP
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.